Results 171 to 180 of about 40,821 (327)

Effects of a novel endothelin ETB receptor antagonist, RES-701-1, on isolated blood vessels.

, 1994
Hideaki Karaki, Sri Agus Sudjarwo, Masatoshi Hori, Takeo Tanaka, Yuzuru Matsuda   +4 more
openalex   +1 more source

A Case of Atrial Septal Defect Unveiled by the Treatment for Pulmonary Arterial Hypertension

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT We present a case of a 51‐year‐old woman with atrial septal defect (ASD) masked by pulmonary arterial hypertension (PAH). Three months after PAH treatment with a combination of endothelin receptor antagonist and phosphodiesterase five inhibitor, the transthoracic echocardiography revealed left‐to‐right shunting through a secundum ASD.
Takaaki Fujii, Sayuri Yamabe, Yoshiro Tsuruta, Yu Kawada, Tatsuya Mizoguchi, Masashi Yokoi, Kento Mori, Tsuyoshi Ito, Shuichi Kitada, Toshihiko Goto, Shigefumi Fukui, Hideo Izawa, Yoshihiro Seo   +12 more
wiley   +1 more source

A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice. [PDF]

Pulm Circ, 2020
Kato T, Mitani Y, Masuya M, Maruyama J, Sawada H, Ohashi H, Ikeyama Y, Otsuki S, Yodoya N, Shinohara T, Miyata E, Zhang E, Katayama N, Shimpo H, Maruyama K, Komada Y, Hirayama M.   +16 more
europepmc   +1 more source

Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels

, 2009
Stéphanie Sauvageau, Éric Thorin, Louis Villeneuve, Jocelyn Dupuis   +3 more
openalex   +2 more sources

Endothelin and other mediators in the pathophysiology of portal hypertension [PDF]

, 1998
Bilzer, Manfred, Gerbes, Alexander L., Gülberg, Veit   +2 more
core   +1 more source

Edible Seeds in the Fight Against Hypertension: A Review of In Vitro, In Vivo, and Clinical Evidences With a Mechanistic Insight of Bioactive Compounds

Food Frontiers, Volume 7, Issue 1, January 2026.
The presented review provides the potential antihypertensive benefits of traditionally employed edible seeds, presenting new perspectives and avenues for future research. ABSTRACT Hypertension, often referred to as a silent killer, is responsible for 7.5 million deaths, representing approximately 12.8% of all global mortality.
Jinmin Shi, Mohamad Fawzi Mahomoodally, Ahmed Abduljalal Abduljabbar, Ruttun Bushra Umme Zainab, Katharigatta N. Venugopala, Gokhan Zengin, Sakina Yagi, Meng‐Yao Li, Xuebo Hu   +8 more
wiley   +1 more source

Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.

J Am Soc Nephrol, 2021
Heerspink HJL, Xie D, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Perkovic V, Rossing P, Parving HH, de Zeeuw D, on behalf on the SONAR Investigators.   +13 more
europepmc   +1 more source

Organocatalytic Enantioselective Conjugate Addition of Nitromethane to Benzylidene-2-Benzoyl Acetate: Asymmetric Synthesis of ABT - 627, an Endothelin Receptor Antagonist. [PDF]

Front Chem, 2020
Hajra S, Aziz SM, Jana B, Hazra S.
europepmc   +1 more source

The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan [PDF]

Thomas Williams, Duuamene Nyimanu, Rhoda E. Kuc, Richard Foster, Robert C. Glen, Janet J. Maguire, Anthony P. Davenport   +6 more
openalex   +1 more source

Anti‐ulcerogenic properties of endothelin receptor antagonists in the rat [PDF]

, 1999
PADOL, Huang, John A. Hunt
openalex   +1 more source